Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

ONADRINE TABLET 50 mg

Approval Number

SIN07611P

Drug Name

ONADRINE TABLET 50 mg

Product Name

ONADRINE TABLET 50 mg

Approval Date

January 18, 1994

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

M03BC01

ATC Item Name

orphenadrine (citrate)

Manufacturer Information

Pharmaceutical Manufacturer

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Manufacturers

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL SDN BHD

Active Ingredients

Ingredient Name

ORPHENADRINE CITRATE

Strength

50 mg

Drug MonographOrphenadrine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

ONADRINE TABLET 50 mg - HSA Approval | MedPath